When corporations want to collaborate with biotech innovators, it is like an accolade - big companies usually take longer to commit. Defence Therapeutics' most recently announced collaboration with French state-owned Orano raises eyebrows for several reasons. Find out what the cooperation in the field of nuclear medicine is all about and what potential could arise from the collaboration.Den vollständigen Artikel lesen ...
© 2023 researchanalyst.com (EN)